Harvard Bioscience
HBIO
#10563
Rank
HK$0.28 B
Marketcap
HK$62.36
Share price
-1.00%
Change (1 day)
1,606.68%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -HK$77.37 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are HK$85.53 Million. In 2025 the company made an earning of -HK$0.46 Billion a decrease over its 2024 earnings that were of -HK$91.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$77.37 Million-82.81%
2025 -HK$0.46 Billion391.95%
2024 -HK$91.51 Million356.38%
2023 -HK$20.06 Million-72.15%
2022 -HK$72.01 Million6456.43%
2021 -HK$1.1 Million-98.08%
2020 -HK$57.21 Million32.53%
2019 -HK$43.16 Million-31.01%
2018 -HK$62.56 Million243.9%
2017 -HK$18.2 Million-24.66%
2016 -HK$24.15 Million-14.69%
2015 -HK$28.31 Million-181.68%
2014 HK$34.64 M-9.97%
2013 HK$38.48 M120%
2012 HK$17.49 M-50.9%
2011 HK$35.62 M-52.51%
2010 HK$75.02 M-2.53%
2009 HK$76.96 M28.26%
2008 HK$60 M-20.05%
2007 HK$75.05 M13.96%
2006 HK$65.86 M17.59%
2005 HK$56 M57.37%
2004 HK$35.59 M-37.31%
2003 HK$56.76 M208.03%
2002 HK$18.42 M-168.71%
2001 -HK$26.83 Million-66.89%
2000 -HK$81.01 Million